Evaluation for liver transplant

Each candidate will be seen by various clinicians from within the University of Maryland Liver Center,Hepatology meeting with patient including the liver transplant screening committee. Members of the Liver Center team meet with patients and provide expert input about any pre-transplant concerns or post-op management issues that may affect the outcome from liver transplantation.

Learn more about the experts that make up the University of Maryland Liver Center

After the evaluation process is completed, the liver transplant screening committee will meet and review the data and make a decision as to the appropriateness and timing of liver transplantation for each patient. Decisions include:

  • Accepted for transplantation
  • Deferred, pending supplemental data
  • Not eligible for transplantation

A formal letter will be sent to each patient and the referring physician relaying the decision of the multidisciplinary screening committee. If a patient is deferred, the patient and referring physician will be notified of the additional required data. 

In addition to the thorough evaluation with the liver transplant screening committee, radiologic and laboratory investigations are performed to elucidate the cause and nature of the liver disease, assess functional capacity, determine patency of hepatic vascular supply, and to exclude co-existing medical conditions that would compromise patient or graft survival.

  • Complete biochemical and liver profile, hepatitis serologies, virology studies (including CMV, EBV, HIV), complete blood count and coagulation profile.
  • Assessment of blood type and presence of any special transfusion related problems.
  • Duplex ultrasound and MRI/MRA of liver to determine portal vein patency and exclude liver masses.
  • Pulmonary and cardiac functional studies (if indicated).
  • Routine cancer screening.

Some patients will require inpatient evaluation due to decompensated cirrhosis or acute hepatic failure. Their pre-transplant management and evaluation will be led by Transplant Hepatology. Patients may require therapeutic, as well as, diagnostic measures to improve their clinical and functional status. Patients with fulminant liver failure will require expedited evaluation and ongoing joint assessment by transplant hepatology and surgery as to the appropriateness and timing for transplantation.


This page was last updated: December 4, 2013

         
Average rating (0)